RHJA
RGEN icon

Rice Hall James & Associates’s Repligen RGEN Stock Holding History

Rice Hall James & Associates’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.57M Sell
18,833
-1,318
-7% -$162K 0.13% 156
2026
Q1 		$2.37M Sell
20,151
-393
-2% -$54.9K 0.13% 151
2025
Q4 		$3.37M Buy
20,544
+1,396
+7% +$219K 0.19% 118
2025
Q3 		$2.56M Sell
19,148
-262
-1% -$31.8K 0.14% 140
2025
Q2 		$2.41M Sell
19,410
-39
-0.2% -$4.96K 0.13% 148
2025
Q1 		$2.47M Buy
19,449
+4,058
+26% +$625K 0.15% 141
2024
Q4 		$2.22M Buy
+15,391
New +$2.21M 0.12% 169
2018
Q4 		– Sell
-31,775
Closed -$1.76M – 305
2018
Q3 		$1.76M Sell
31,775
-19,876
-38% -$1.02M 0.06% 204
2018
Q2 		$2.43M Sell
51,651
-500
-1% -$20.6K 0.09% 161
2018
Q1 		$1.89M Sell
52,151
-11,232
-18% -$395K 0.07% 194
2017
Q4 		$2.3M Sell
63,383
-3,776
-6% -$137K 0.09% 180
2017
Q3 		$2.57M Sell
67,159
-213
-0.3% -$8.93K 0.11% 159
2017
Q2 		$2.79M Sell
67,372
-3,764
-5% -$143K 0.12% 130
2017
Q1 		$2.5M Sell
71,136
-1,700
-2% -$53.8K 0.12% 148
2016
Q4 		$2.25M Sell
72,836
-600
-0.8% -$18.6K 0.11% 164
2016
Q3 		$2.22M Sell
73,436
-200
-0.3% -$6.04K 0.12% 163
2016
Q2 		$2.02M Sell
73,636
-1,772
-2% -$45.3K 0.12% 171
2016
Q1 		$2.02M Buy
75,408
+200
+0.3% +$4.89K 0.12% 166
2015
Q4 		$2.13M Sell
75,208
-700
-0.9% -$20.2K 0.12% 163
2015
Q3 		$2.11M Buy
75,908
+1,100
+1% +$39.8K 0.14% 161
2015
Q2 		$3.09M Sell
74,808
-419
-0.6% -$15.3K 0.18% 128
2015
Q1 		$2.28M Sell
75,227
-52,159
-41% -$1.35M 0.13% 181
2014
Q4 		$2.52M Sell
127,386
-599
-0.5% -$13.4K 0.15% 171
2014
Q3 		$2.55M Sell
127,985
-84,866
-40% -$1.79M 0.18% 157
2014
Q2 		$4.85M Sell
212,851
-1,774
-0.8% -$31.6K 0.33% 63
2014
Q1 		$2.76M Sell
214,625
-68,106
-24% -$977K 0.2% 145
2013
Q4 		$3.86M Sell
282,731
-13,800
-5% -$165K 0.28% 81
2013
Q3 		$3.29M Sell
296,531
-600
-0.2% -$5.97K 0.32% 87
2013
Q2 		$2.45M Buy
+297,131
New +$2.5M 0.24% 123

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Rice Hall James & Associates's RGEN Position: Q2 2026 in Review

Rice Hall James & Associates reduced its Repligen (RGEN) stake by 6.5% in Q2 2026, selling an estimated $162K and leaving 18,833 shares worth $2.57M. The position accounts for 0.13% of the portfolio, ranked #156.

Rice Hall James & Associates first reported a position in RGEN in Q2 2013 and has held it in 29 quarters since. The position peaked at $4.85M in Q2 2014. 481 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Rice Hall James & Associates held 18,833 shares of Repligen worth $2.57M as of Q2 2026.
  • Rice Hall James & Associates sold 1,318 Repligen shares in Q2 2026, an estimated $162K.
  • Repligen made up 0.13% of Rice Hall James & Associates's portfolio in Q2 2026, its #156 holding.
  • Rice Hall James & Associates first reported a position in Repligen in Q2 2013 and has held it in 29 quarters since.
  • Rice Hall James & Associates's Repligen position peaked at $4.85M in Q2 2014.
  • 481 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Rice Hall James & Associates's 13F filing for Q2 2026, filed 7 Aug 2026.